logo

FDA Calendar

Share
PDUFA dates and FDA Panel Review dates are very important because they are make or break events for biostocks when the decisions are announced. Also, usually biostocks experience a run-up going into the scheduled decision/review dates. So having prior knowledge of the catalysts goes a long way toward maximizing profit or minimizing loss while trading volatile biotech stocks.
Listed below are large cap, mid cap and small cap stocks with pending regulatory catalysts.

Get in-depth analysis and insight on investing in the high-stakes biotech and pharma sectors. Check out our premium biotech research product and our biotech home page.
Company Name
Ticker
Drug
Event
Date
Outcome
Details
Foamix Pharmaceuticals Ltd.
FMX103 topical foam (NDA)
FDA decision on FMX103 for the treatment of moderate-to-severe papulopustular rosacea in adults.
06/02/2020
PTC Therapeutics Inc.
Risdiplam (NDA)
FDA decision on Risdiplam for the treatment of spinal muscular atrophy
05/24/2020
Roche Holding AG
Risdiplam (NDA)
FDA decision on risdiplam for spinal muscular atrophy
05/24/2020
Sumitomo Dainippon Pharma
Dasotraline (NDA)
FDA decision on Dasotraline for the treatment of patients with moderate-to-severe binge eating disorder
05/14/2020
Halozyme Therapeutics, Inc.
DARZALEX (BLA)
FDA decision on subcutaneous delivery of DARZALEX for patients with multiple myeloma.
05/12/2020
Sanofi
Isatuximab (BLA)
FDA decision on Isatuximab b for the treatment of patients with relapsed/refractory multiple myeloma
04/30/2020
United Therapeutics Corp
Trevyent (UTHR)
FDA decision on Trevyent for the treatment of pulmonary arterial hypertension
04/27/2020
Correvio Pharma Corp.
Trevyent (NDA)
FDA decision on Trevyent for the treatment of pulmonary arterial hypertension
04/27/2020
Neurocrine Biosciences Inc
Opicapone (NDA)
FDA decision on Opicapone as an adjunctive treatment to levodopa/carbidopa in patients with Parkinson's disease experiencing OFF episodes.
04/26/2020
Sanofi
MenQuadfi (BLA)
FDA decision on MenQuadfi to prevent meningococcal meningitis
04/25/2020
AstraZeneca PLC
AZN.L, AZN
Trastuzumab deruxtecan (BLA)
FDA decision on Trastuzumab deruxtecan or treatment of patients with HER2-positive metastatic breast cancer
04/17/2020
Eli Lilly And Co.
Empagliflozin/Iinagliptin/Metformin Triple Combination Tablet (NDA)
FDA decision on the triple combination tablet for adults with Type 2 Diabetes
04/04/2020
Celgene Corporation
Luspatercept (BLA)
FDA decision on Luspatercept for adult patients with very low- to intermediate-risk MDS-associated anemia
04/04/2020
Acceleron Pharma, Inc
Luspatercept (BLA)
FDA decision on Luspatercept for adult patients with very low- to intermediate-risk MDS-associated anemia
04/04/2020
Rockwell Medical Technologies Inc
IV Triferic (NDA)
FDA decision on IV Triferic for iron deficiency in chronic kidney disease patients receiving hemodialysis
03/28/2020
Buy this Content


pharma053117_10dec19.jpg Today's Daily Dose brings you news about the FDA panel's vote on Correvio Pharma's anti-arrhythmic drug Brinavess; the near-term catalyst of Eloxx Pharma; the phase III trial results of Iterum's Sulopenem in the treatment of complicated intra-abdominal infections, and Xeris Pharma's phase II study results of ready-to-use (RTU) glucagon.
pharma-061417_10dec19.jpg Today's Daily Dose brings you news about Aurinia Pharma's secondary offering; Aptose Biosciences' early clinical data of CG-806 and APTO-253; the proposed reverse stock split of Protalix BioTherapeutics and Gilead's path forward for KTE-X19 in the treatment for relapsed or refractory mantle cell lymphoma.
pharmaup-dec09.jpg The following are some of today's top gainers in the healthcare sector.
Read More
CannTrust Holdings Inc. said that the New York Stock Exchange or NYSE notified the embattled Canada-based cannabis company that it is no longer in compliance with the NYSE's continued listing standard rules as the company's per share trading price has fallen below the stock exchange's share price rule. The...
Canadian pharmacy chain Shoppers Drug Mart has recently expanded Medical Cannabis by Shoppers, its online platform for the sale of medical cannabis, to all provinces and territories in Canada. The company recently announced the expansion of its medical cannabis portal to include Nova Scotia, British...
Maine released marijuana facility applications for adult use marijuana cultivation, manufacturing and retail facilities in the state last week. The Office of Marijuana Policy, a part of the Maine Department of Administrative and Financial Services, said that prospective licensees may immediately...
Read More
>